MedPath

An investigation on the visceral fat reduction effect and the safety of coffee.

Not Applicable
Conditions
/A(People with a BMI of at least 25 kg/m2 and less than 30kg/m2.)
Registration Number
JPRN-UMIN000033084
Lead Sponsor
Tsuguyoshi Asano
Brief Summary

In the blood and urine examination, blood pressure, heart rate and subjective symptom did not show adverse effects. In conclusion,compared with control coffee, the chlorogenic acids-enriched coffee was significantly effective and safe to decrease visceral fat and serum triglyceride.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
62
Inclusion Criteria

Not provided

Exclusion Criteria

1. People who have very irregular dietary habits 2. People on continuous treatment with medication 3. People with medicine or food allergies 4. People using medicine, foods for specified health uses, foods with functional claims, supplements, or diet products that may have an effect on the study 5. People with hypertension , diabetes mellitus, dyslipidemia ,or other lifestyle-related diseases 6. People with gastrointestinal dysfunction, significant liver dysfunction, significant kidney dysfunction, or significant cardiovascular disease 7. People with a history of a gastrectomy/extensive digestive tract excision 8. People with dependence on drugs or alcohol 9. People who are pregnant, nursing, or plan to become pregnant 10. Other people determined to be unsuitable for participation in the study by the principal investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visceral Fat Measured at initial, 4 week, 8 week, and 12 week visits
Secondary Outcome Measures
NameTimeMethod
Weight Measured at initial, 4 week, 8 week, and 12 week visits BMI Measured at initial, 4 week, 8 week, and 12 week visits Waist Circumference Measured at initial, 4 week, 8 week, and 12 week visits
© Copyright 2025. All Rights Reserved by MedPath